Recrudescence of malignant hyperthermia

Anesthesiology

Volumn 106, Issue 5, 2007, Pages 893-894

  Hopkins, Philip M ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; RYANODINE RECEPTOR 1;

ANESTHESIA INDUCTION; ANTHROPOMETRY; BODY BUILD; BODY TEMPERATURE; CALCIUM TRANSPORT; CLINICAL FEATURE; CLINICAL PRACTICE; CRITICALLY ILL PATIENT; DIFFERENTIAL DIAGNOSIS; DISEASE PREDISPOSITION; DISEASE SEVERITY; EDITORIAL; GENE MUTATION; GENETIC PREDISPOSITION; HUMAN; INCIDENCE; INTENSIVE CARE; MALIGNANT HYPERTHERMIA; PATIENT MONITORING; PRIORITY JOURNAL; SCORING SYSTEM;

CALCIUM; HUMANS; LOGISTIC MODELS; MALIGNANT HYPERTHERMIA; MUTATION; RECURRENCE; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL;

EID: 34247620807     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/01.anes.0000265144.63696.af     Document Type: Editorial

References (11)

1. Burkman JM, Posner KL, Domino KB: Analysis of the clinical variables associated with recrudescence after malignant hyperthermia reactions. ANESTHESIOLOGY 2007; 106:901-6
2. Hopkins PM: Malignant hyperthermia: Advances in clinical management and diagnosis. Br J Anaesth 2000; 85:118-28
3. Larach MG, Localio AR, Allen GC, Denborough MA, Ellis FR, Gronert GA, Kaplan RF, Muldoon SM, Nelson TE, Ording H, Rosenberg H, Waud BE, Wedel DJ: A clinical grading scale to predict malignant hyperthermia susceptibility. ANESTHESIOLOGY 1994; 80:771-9
4. Campbell IT, Ellis FR, Halsall PJ, Hogge MS: Anthropometric studies of human subjects susceptible to malignant hyperpyrexia. Acta Anaesthesiol Scand 1982; 36:363-7
5. Yamazawa T, Takeshima H, Sakurai T, Endo M, Iino M: Subtype specificity of the ryanodine receptor for Ca2+ signal amplification in excitation- contraction coupling. EMBO J 1996; 15:6172-7
6. Short JA, Cooper CM: Suspected recurrence of malignant hyperthermia after postextubation shivering in the intensive care unit, 18 h after tonsillectomy. Br J Anaesth 1999; 82:945-7
7. Mathieu A, Bogosian AJ, Ryan JF, Crone RK, Crocker D: Recrudescence after survival of an initial episode of malignant hyperthermia. A NESTHESIOLOGY 1979; 51:454-5
8. Robinson RL, Brooks C, Brown SL, Ellis FR, Halsall PJ, Quinnell RJ, Shaw M-A, Hopkins PM: RYR1 mutations causing central core disease are associated with more severe malignant hyperthermia in vitro contracture test phenotypes. Hum Mut 2002; 20:88-97
9. Robinson RL, Carpenter D, Shaw M-A, Halsall PJ, Hopkins PM: Mutations in RYR1 in malignant hyperthermia and central core disease. Hum Mut 2006; 27:977-89
10. Sei Y, Sambuughin N, Davis E, Sachs D, Cuenca P, Brandom B, Tautz T, Rosenberg H, Nelson TE, Muldoon SM: Malignant hyperthermia in North America: Genetic screening of the three hot spots in the type I ryanodine receptor gene. ANESTHESIOLOGY 2004; 101:824-30
11. Sambuughin N, Holley H, Muldoon S, Brandom BW, Bantel AM, Tobin JR, Nelson TE, Goldfarb LG: Screening the entire ryanodine receptor type 1 coding region for sequence variants associated with malignant hyperthermia susceptibility in the North American population. ANESTHESIOLOGY 2005; 102:515-21